Mass General - Division of Clinical Research

for Patients: - English speaking adult patients with cancer (18 years or older) - Treated at MGH, who are either within approximately: - 3 months to 3 years after completing potentially curative therapy for cancer diagnosis including surgery, radiation, and/or chemotherapy or other novel therapies (e.g., immunotherapy, biological therapy). Patients can be on long- term maintenance hormonal or biological therapy at the time of enrollment. - 6 months to 3 years after diagnosis of metastatic disease with an expected prognosis of >1 year as confirmed by the treating oncology clinician - Able to identify a caregiver (i.e., spouse/partner or patient-identified family member or friend) who is willing to participate in the study

for Patients: - Prognosis less than one year as determined by the treating oncology clinician - Active psychiatric or cognitive comorbidity that prohibits the capacity to provide informed consent as determined by the treating oncology clinician - Patients without a caregiver who is willing to participate Inclusion Criteria for Caregivers: - Adult caregiver (age 18 years or older). - Identified by the patient as the spouse/partner or family member/friend.